Experts Doubt Necessity of Policy Intervention for LLP-Dependent Companies

January 27, 2023
MHLW Expert Panel on Comprehensive Pharmaceutical Policies on Jan. 26 Is policy intervention necessary for Japanese drug makers reliant on off-patent brand-name medicines? Many members of the health ministry’s key expert panel appear to doubt it, in the belief that...read more